Clinigen clears out cancer therapies in line with latest growth strategy
Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.
Following the business expansion in 2022, Clinigen announced the divestment of four of its cancer therapies.
What's Your Reaction?
